510(k) Report

FDA applicant

Stryker Neurovascular

Fremont, CA36 decisions2011–202646 recalls

FDA records 36 decisions for Stryker Neurovascular (Fremont, CA) from 2011 to 2026: 34 510(k) clearances and 2 original PMA approvals. Most are in product codes HCG (Device, Neurovascular Embolization) and QJP (Catheter, Percutaneous, Neurovasculature). Since 2016 its 510(k)s took a median of 114 days from receipt to decision, against 111 for FDA’s reviews in the same codes and years. Its devices cite 44 predicates, 20 of them its own earlier devices. 46 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Stryker Neurovascular’s devices, and how often a recall has named them.

FDA decisions per year

4in 2025

2011: 22012: 32013: 22014: 12016: 32017: 12018: 12019: 52020: 32021: 42022: 12023: 12024: 22025: 42026 (partial year): 3
2011high 5 (2019) · low 0 (2015)2026

2026 so far, outlined.

Recalls per year

1in 2026

2013: 82014: 12016: 282017: 32023: 12024: 42026 (partial year): 1
2011high 28 (2016) · low 0 (2011)2026

Class I Class II/III not classified

FIG. 1 — Stryker Neurovascular by year, 2011–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Stryker Neurovascular’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Stryker”

FDA records each applicant name separately; these may or may not be the same firm.